Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
allogeneic cell therapy
Biotech
Nkarta's blood cancer CAR stalls again, driving deprioritization
The response rate fell away sharply in the latest update, promoting the NK cell therapy developer to mothball the program.
Nick Paul Taylor
Mar 22, 2024 9:11am
After ph. 2 fail, Atara says goodbye to CMO and 25% of staff
Jan 31, 2024 11:22am
Precision deals out CAR-T autoimmune rights to TG for $10M
Jan 9, 2024 10:14am
Vertex pauses diabetes cell therapy trial after 2 deaths
Jan 7, 2024 5:00pm
Allogene stops pivotal trials, pursues first-line CAR-T cures
Jan 5, 2024 8:55am
Vor Bio's dual stem cell, ADC shows consistent engraftment
Nov 9, 2023 4:10pm